Cytocor's research into Endometrial Cancer

Article
Conferences|SGO

SGO Annual Meeting on Women’s Cancer in San Diego from March 3-7, 2007


The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of Windows Media Player, available here.

Related Videos
What's new in endometrium care? | Image Credit: nyulangone.org
New algorithm to identify benign lesions developed | Image Credit: nemours.mediaroom.com
Anne Banfield, MD | Image Credit: © Medstar
Jonathan Miller, MD
Honoring Endometriosis Awareness Month | Image Credit: © Katsiaryna Hatsak - © Katsiaryna Hatsak - stock.adobe.com
Related Content
Dostarlimab shows significant survival benefits in endometrial cancer trial | Image Credit: © John Doe - © John Doe - stock.adobe.com.

Dostarlimab shows significant survival benefits in endometrial cancer trial

March 21st 2024
Article

GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.

Read More

S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH

S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH

February 19th 2021
Podcast

On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.

Listen

Unifying radical hysterectomy classifications with the Querleu-Morrow | Image Credit: © Flamingo Images - © Flamingo Images - stock.adobe.com.

Unifying radical hysterectomy classifications with the Querleu-Morrow

February 16th 2024
Article

Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.

Read More

Long-term outcomes of relugolix combination therapy for severe endometriosis | Image Credit: © smolaw11 - © smolaw11 - stock.adobe.com.

Long-term outcomes of relugolix combination therapy for severe endometriosis

January 26th 2024
Article

A recent study unveiled the sustained safety and efficacy of relugolix combination therapy over 2 years.

Read More

Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more | Image Credit: © Aleksey 159 - © Aleksey 159 - stock.adobe.com.

Contemporary OB/GYN week in review: abortion bans, HPV vaccination, and more

January 19th 2024
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Read More

Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment | Image Credit: © Minerva Studio - © Minerva Studio - stock.adobe.com.

Racial and ethnic disparities found in gynecologic oncology clinical trial enrollment

January 15th 2024
Article

A recent study revealed disparities in gynecologic oncology clinical trial enrollment, impacting the outcomes of underrepresented racial and ethnic groups.

Read More

© 2024 MJH Life Sciences

All rights reserved.